Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 465 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Phase: Phase 3 to Not specifiedv465 Show 4 more changesShow less
    • Primary and study completion dates: Sep 30, 2025 to Apr 4, 2027
    • Trial status: Completed to Active, Not Recruiting
    • Enrollment target: 701 to not stated
    • Site details revised at 4 of 386 sites
  2. Trial status: Active, Not Recruiting to Completed
    • Study completion date changed from estimate of Dec 2025 to Sep 30, 2025
    v464
  3. Primary completion date: Apr 30, 2024 to Sep 30, 2025
    • Study completion date: Dec 2024 to Dec 2025
    v463
  4. Primary completion date changed from estimate of Apr 2024 to Apr 30, 2024v462
  5. Re-verified, no change to tracked fieldsv461
Show 45 earlier versionsHide 45 earlier versions
  1. Start date: Jun 2007 to Oct 12, 2007
    • Study completion date: Dec 2024
    v460
  2. Re-verified, no change to tracked fieldsv459
  3. Primary completion date: Mar 2021 to Apr 2024v458
  4. 2 versions Re-verified since Jul 1, 2019, no change to tracked fieldsv456-v457
  5. Site details revised at 1 of 386 sitesv455
  6. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 1258 to confirmed 701
    • Study sites: 425 to 386
    v454
  7. Study sites revised (425)v453
  8. Study sites: 193 to 425v452
  9. Re-verified, no change to tracked fieldsv451
  10. Study sites: 65 to 193v450
  11. Lead sponsor: Cancer and Leukemia Group B to Alliance for Clinical Trials in Oncologyv449 Show 7 more changesShow less
    • Study sites: 149 to 65
    • Interventions: therapeutic thoracoscopy (Procedure), videothoracoscopy (Procedure) to lobectomy (Procedure), segmentectomy or wedge resection (Procedure)
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints revised (3)
    • Primary endpoint revised
    • Collaborators: 4 to 1
    • Study description expanded, about 1 word
  12. Study sites: 147 to 149v448
  13. Study sites: 146 to 147v447
  14. Study sites: 147 to 146v446
  15. Study sites: 148 to 147v445
  16. Re-verified, no change to tracked fieldsv444
  17. Study sites: 147 to 148v443
  18. Study sites: 148 to 147v442
  19. Study sites: 147 to 148v441
  20. Study sites: 148 to 147v440
  21. Study sites: 139 to 148v439
  22. Study sites: 138 to 139v438
  23. Study sites: 120 to 138v437
  24. Study sites: 119 to 120v436
  25. Re-verified, no change to tracked fieldsv435
  26. Study sites: 118 to 119v434
  27. Study sites: 117 to 118v433
  28. Study sites: 116 to 117v432
  29. Study sites: 115 to 116v431
  30. Study sites: 116 to 115v430
  31. Study sites: 119 to 116v429
  32. Study sites: 120 to 119v428
  33. Study sites: 110 to 120v427
  34. Study sites: 109 to 110v426
  35. Site contacts updated at 1 of 109 sitesv425
  36. Study sites: 108 to 109v424
  37. Study sites: 107 to 108v423
  38. Study sites: 106 to 107v422
  39. Study sites: 105 to 106v421
  40. Study sites: 106 to 105v420
  41. Study sites: 108 to 106v419
  42. Study sites: 107 to 108v418
  43. Study sites: 106 to 107v417
  44. Study sites: 107 to 106v416
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RATIONALE: Wedge resection or segmentectomy may be less invasive types of surgery than lobectomy for non-small cell lung cancer and may have fewer side effects and improve recovery. It is not yet known whether wedge resection or segmentectomy are more effective than lobectomy in treating stage IA non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying different types of surgery to compare how well they work in treating patients with stage IA non-small cell lung cancer.
Trial Details
NCT Number NCT00499330
Lead Sponsor Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Lung Cancer
Related terms Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov